Title : Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38 - Dodds_1998_J.Pharmacol.Exp.Ther_286_578 |
Author(s) : Dodds HM , Haaz MC , Riou JF , Robert J , Rivory LP |
Ref : Journal of Pharmacology & Experimental Therapeutics , 286 :578 , 1998 |
Abstract : |
PubMedSearch : Dodds_1998_J.Pharmacol.Exp.Ther_286_578 |
PubMedID: 9655905 |
Title : The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms - Haaz_1997_Naunyn.Schmiedebergs.Arch.Pharmacol_356_257 |
Author(s) : Haaz MC , Rivory LP , Riche C , Robert J |
Ref : Naunyn Schmiedebergs Arch Pharmacol , 356 :257 , 1997 |
Abstract : |
PubMedSearch : Haaz_1997_Naunyn.Schmiedebergs.Arch.Pharmacol_356_257 |
PubMedID: 9272733 |
Title : Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients - Rivory_1996_Cancer.Res_56_3689 |
Author(s) : Rivory LP , Riou JF , Haaz MC , Sable S , Vuilhorgne M , Commercon A , Pond SM , Robert J |
Ref : Cancer Research , 56 :3689 , 1996 |
Abstract : |
PubMedSearch : Rivory_1996_Cancer.Res_56_3689 |
PubMedID: 8706009 |